These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 18416543)

  • 1. Aza-peptidyl Michael acceptors. A new class of potent and selective inhibitors of asparaginyl endopeptidases (legumains) from evolutionarily diverse pathogens.
    Götz MG; James KE; Hansell E; Dvorák J; Seshaadri A; Sojka D; Kopácek P; McKerrow JH; Caffrey CR; Powers JC
    J Med Chem; 2008 May; 51(9):2816-32. PubMed ID: 18416543
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aza-peptidyl Michael acceptor and epoxide inhibitors--potent and selective inhibitors of Schistosoma mansoni and Ixodes ricinus legumains (asparaginyl endopeptidases).
    Ovat A; Muindi F; Fagan C; Brouner M; Hansell E; Dvorák J; Sojka D; Kopácek P; McKerrow JH; Caffrey CR; Powers JC
    J Med Chem; 2009 Nov; 52(22):7192-210. PubMed ID: 19848405
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aza-peptide epoxides: potent and selective inhibitors of Schistosoma mansoni and pig kidney legumains (asparaginyl endopeptidases).
    James KE; Götz MG; Caffrey CR; Hansell E; Carter W; Barrett AJ; McKerrow JH; Powers JC
    Biol Chem; 2003 Dec; 384(12):1613-8. PubMed ID: 14719804
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design, synthesis, and evaluation of aza-peptide Michael acceptors as selective and potent inhibitors of caspases-2, -3, -6, -7, -8, -9, and -10.
    Ekici OD; Li ZZ; Campbell AJ; James KE; Asgian JL; Mikolajczyk J; Salvesen GS; Ganesan R; Jelakovic S; Grütter MG; Powers JC
    J Med Chem; 2006 Sep; 49(19):5728-49. PubMed ID: 16970398
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aza-peptide Michael acceptors: a new class of inhibitors specific for caspases and other clan CD cysteine proteases.
    Ekici OD; Götz MG; James KE; Li ZZ; Rukamp BJ; Asgian JL; Caffrey CR; Hansell E; Dvorák J; McKerrow JH; Potempa J; Travis J; Mikolajczyk J; Salvesen GS; Powers JC
    J Med Chem; 2004 Apr; 47(8):1889-92. PubMed ID: 15055989
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and evaluation of peptidyl Michael acceptors that inactivate human rhinovirus 3C protease and inhibit virus replication.
    Kong JS; Venkatraman S; Furness K; Nimkar S; Shepherd TA; Wang QM; Aubé J; Hanzlik RP
    J Med Chem; 1998 Jul; 41(14):2579-87. PubMed ID: 9651162
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aza-peptide epoxides: a new class of inhibitors selective for clan CD cysteine proteases.
    Asgian JL; James KE; Li ZZ; Carter W; Barrett AJ; Mikolajczyk J; Salvesen GS; Powers JC
    J Med Chem; 2002 Nov; 45(23):4958-60. PubMed ID: 12408706
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design, synthesis, and evaluation of aza-peptide epoxides as selective and potent inhibitors of caspases-1, -3, -6, and -8.
    James KE; Asgian JL; Li ZZ; Ekici OD; Rubin JR; Mikolajczyk J; Salvesen GS; Powers JC
    J Med Chem; 2004 Mar; 47(6):1553-74. PubMed ID: 14998341
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel aza peptide inhibitors and active-site probes of papain-family cysteine proteases.
    Verhelst SH; Witte MD; Arastu-Kapur S; Fonovic M; Bogyo M
    Chembiochem; 2006 Jun; 7(6):943-50. PubMed ID: 16607671
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of mammalian legumain by Michael acceptors and AzaAsn-halomethylketones.
    Niestroj AJ; Feussner K; Heiser U; Dando PM; Barrett A; Gerhartz B; Demuth HU
    Biol Chem; 2002; 383(7-8):1205-14. PubMed ID: 12437107
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IrAE: an asparaginyl endopeptidase (legumain) in the gut of the hard tick Ixodes ricinus.
    Sojka D; Hajdusek O; Dvorák J; Sajid M; Franta Z; Schneider EL; Craik CS; Vancová M; Buresová V; Bogyo M; Sexton KB; McKerrow JH; Caffrey CR; Kopácek P
    Int J Parasitol; 2007 Jun; 37(7):713-24. PubMed ID: 17336985
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Specificity of aza-peptide electrophile activity-based probes of caspases.
    Sexton KB; Kato D; Berger AB; Fonovic M; Verhelst SH; Bogyo M
    Cell Death Differ; 2007 Apr; 14(4):727-32. PubMed ID: 17170749
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Arylaminoethyl amides as noncovalent inhibitors of cathepsin S. Part 2: Optimization of P1 and N-aryl.
    Alper PB; Liu H; Chatterjee AK; Nguyen KT; Tully DC; Tumanut C; Li J; Harris JL; Tuntland T; Chang J; Gordon P; Hollenbeck T; Karanewsky DS
    Bioorg Med Chem Lett; 2006 Mar; 16(6):1486-90. PubMed ID: 16412634
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Asparaginyl endopeptidase activity in adult Schistosoma mansoni.
    Dalton JP; Hola-Jamriska L; Brindley PJ
    Parasitology; 1995 Dec; 111 ( Pt 5)():575-80. PubMed ID: 8559590
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design and synthesis of novel 2-pyridone peptidomimetic falcipain 2/3 inhibitors.
    Verissimo E; Berry N; Gibbons P; Cristiano ML; Rosenthal PJ; Gut J; Ward SA; O'Neill PM
    Bioorg Med Chem Lett; 2008 Jul; 18(14):4210-4. PubMed ID: 18554905
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peptidyl allyl sulfones: a new class of inhibitors for clan CA cysteine proteases.
    Götz MG; Caffrey CR; Hansell E; McKerrow JH; Powers JC
    Bioorg Med Chem; 2004 Oct; 12(19):5203-11. PubMed ID: 15351403
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Entry into a new class of potent proteasome inhibitors having high antiproliferative activity by structure-based design.
    Furet P; Imbach P; Noorani M; Koeppler J; Laumen K; Lang M; Guagnano V; Fuerst P; Roesel J; Zimmermann J; García-Echeverría C
    J Med Chem; 2004 Sep; 47(20):4810-3. PubMed ID: 15369383
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New m-calpain substrate-based azapeptide inhibitors.
    Bánóczi Z; Tantos Á; Farkas A; Majer Z; Dókus LE; Tompa P; Hudecz F
    J Pept Sci; 2013 Jun; 19(6):370-6. PubMed ID: 23613308
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Azadipeptide nitriles: highly potent and proteolytically stable inhibitors of papain-like cysteine proteases.
    Löser R; Frizler M; Schilling K; Gütschow M
    Angew Chem Int Ed Engl; 2008; 47(23):4331-4. PubMed ID: 18404765
    [No Abstract]   [Full Text] [Related]  

  • 20. A general solid phase method for the preparation of diverse azapeptide probes directed against cysteine proteases.
    Kato D; Verhelst SH; Sexton KB; Bogyo M
    Org Lett; 2005 Dec; 7(25):5649-52. PubMed ID: 16321013
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.